Human CD172a Protein, His Tag
- 
									
产品编号
KMP2405
 - 
									
别名
信号调节蛋白, CD172a, SHPS-1
 - 
									
规格
- 50ug
 - 100ug
 - 200ug
 
 
| Catalog Number | KMP2405 | 
| Alias | 信号调节蛋白, CD172a, SHPS-1 | 
| Size | 50ug, 100ug, 200ug | 
| Product Description | The Human CD172a Protein(KMP2405) is produced in HEK293 Cells and the target gene encoding Glu31-Arg370 is expressed with a 6His tag at the C-terminus. | 
| Molecular Name | CD172a | 
| Product Introduction | CD172a(SIRPα):免疫球蛋白超家族(IgSF)成员,主要表达于髓系细胞,参与细胞间识别和信号转导。 | 
| Molecular Weight | 38.14 kDa | 
| Expression System | HEK293 Cells | 
| Species | Human | 
| Purity | >95% | 
| SDS-PAGE | ![]()  | 
| Purification | Affinity Purification | 
| Uniprot ID | P29350 | 
| Storage Condition | Aliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles. | 
| Formulation | PBS, pH7.4 | 
| Shipping Condition | In general, the proteins are provided as lyophilized powder which are shipped at ambient temperature. They are shipped out in dry ice if supplied in liquid form. | 
| Background | Signal Regulatory Protein α(SIRPα) is a monomeric approximately 90 kD type I transmembrane glycoprotein. The 504 amino acid human SIRPα contains two Ig-like C1-type domains and one Ig-like V-type domain. SIRPα can express in various tissues, mainly on brain and myeloid cells, including macrophages, neutrophils, dendritic and Langerhans cells. It also can detect in neurons, smooth muscle and endothelial cells. SIRPA is an immunoglobulin-like cell surface receptor for CD47. SIRPα acts as docking protein and induces translocation of PTPN6, PTPN11 and other binding partners from the cytosol to the plasma membrane. SIRPα shows adhesion of cerebellar neurons, neurite outgrowth and glial cell attachment. SIRPα engagement generally produces a negative regulatory signal; it may mediate negative regulation of phagocytosis, mast cell activation and dendritic cell activation | 
| Endotoxin | <1.0 EU/ug determined by the LAL method | 
| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 | 
可在纯化过程中加入蛋白酶抑制剂、低温操作,优化储存条件(如分装冻存于-80°C),并避免反复冻融。某些情况下,可选用蛋白酶缺陷型宿主菌减少降解风险。
常用SDS-PAGE、Western Blot检测表达,BCA/Bradford法测浓度,HPLC或质谱分析纯度,生物活性实验(如ELISA、酶活检测)验证功能。
							
							
							
							
						
								0